Given its wide range of influence, the HGF/c-MET pathway has been the focus of numerous studies, aiming to reveal its complexities and the potential implications of its dysregulation in pathological conditions such as cancer, fibrosis, and other diseases. The gene discussed is MET; the disease is cancer.